To Study the Effects of Host Genetic Factors on Liver Cirrhosis

The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of liver cirrhosis .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Cirrhosis Digestive System Diseases Fibrosis Liver Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Scientific Center of Surgery named after A.N. Syzganova

Almaty, Kazakhstan

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hepatitis B

Exclusion criteria

the casual aget of liver disease is not viral infection, such as alcohol abuse

Treatment and study plan

SNP analysis of the DNA

Genetic

SNP analysis of the DNA obtained from peripheral blood sample

Primary outcomes

genotyping for the SNP associated with liver cirrhosis

Time frame: 1 year

Genotype frequency of SNP in the study genes of participants and control participants.

Sponsors and collaborators

Lead sponsor

Asfendiyarov Kazakh National Medical University

Other

Registry information

Official study title

Preventive and Personalized Medicine (2021-2023)

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Oct 27, 2021
Registry last updated: Mar 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed